APA (7th ed.) Citation

Vaia Lambadiari, John Thymis, Dimitris Kouretas, Zoi Skaperda, Fotios Tekos, Foteini Kousathana, . . . Ignatios Ikonomidis. (2021). Effects of a 12-Month Treatment with Glucagon-like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Oxidant and Antioxidant Biomarkers in Patients with Type 2 Diabetes. MDPI AG.

Chicago Style (17th ed.) Citation

Vaia Lambadiari, et al. Effects of a 12-Month Treatment with Glucagon-like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Oxidant and Antioxidant Biomarkers in Patients with Type 2 Diabetes. MDPI AG, 2021.

MLA (9th ed.) Citation

Vaia Lambadiari, et al. Effects of a 12-Month Treatment with Glucagon-like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Oxidant and Antioxidant Biomarkers in Patients with Type 2 Diabetes. MDPI AG, 2021.